The pathophysiological relevance of these findings is further demonstrated by the observation that SHP-1 expression is increased in the liver of high-fat fed obese mice and that SHP-1 genetic deletion reduced fasting hyperglycemia but also fully blunted the elevated glucose production in these obese mice (3). The gene discussed is PTPN6; the disease is Hyperglycemia.